TA Associates-backed OmniActive explores $200-300 million IPO at $1 bn valuation
Indian markets moved higher in an ipo & listings development.
· LiveMint Companies
The IPO plan follows several unsuccessful attempts to raise private capital, as macroeconomic headwinds and geopolitical conflicts weighed on investor sentiment. If the IPO goes as planned, it would make OmniActive the first pure-play nutraceutical company to list on the exchanges.
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Market context
- Sectors in the story: Capital Goods & Engineering and Capital Markets.
Capital Goods & Engineering
1M -10.9% · 3M -5.3%
Capital Markets
1M -2.9% · 3M -6.3%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
BLS Polymers IPO allotment likely today; GMP hints at 45% listing gain. Here's how to check status
Well-priced IPOs will build long-term market credibility: Kamraj Negi
Michael Burry says Anthropic IPO papers show AI industry is 'catastrophically vulnerable'. What the 'Big Short' investor sees
Sammaan Capital promoter raises stake to 33.32% after warrant conversion
Aditya Birla Capital Q2 profit rises 38% to Rs 1,288-cr